287 related articles for article (PubMed ID: 8398688)
1. Tumourigenesis associated with the p53 tumour suppressor gene.
Chang F; Syrjänen S; Tervahauta A; Syrjänen K
Br J Cancer; 1993 Oct; 68(4):653-61. PubMed ID: 8398688
[TBL] [Abstract][Full Text] [Related]
2. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang F; Syrjänen S; Kurvinen K; Syrjänen K
Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
[TBL] [Abstract][Full Text] [Related]
3. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
Stein T; Crighton D; Boyle JM; Varley JM; White RJ
Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
5. [P53 and cancers].
May P; May E
Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
[TBL] [Abstract][Full Text] [Related]
6. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
Olive KP; Tuveson DA; Ruhe ZC; Yin B; Willis NA; Bronson RT; Crowley D; Jacks T
Cell; 2004 Dec; 119(6):847-60. PubMed ID: 15607980
[TBL] [Abstract][Full Text] [Related]
8. p53 and human cancers.
Lane DP
Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
[TBL] [Abstract][Full Text] [Related]
9. Implications of the p53 tumor-suppressor gene in clinical oncology.
Chang F; Syrjänen S; Syrjänen K
J Clin Oncol; 1995 Apr; 13(4):1009-22. PubMed ID: 7707100
[TBL] [Abstract][Full Text] [Related]
10. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
Wang XW; Harris CC
Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
[TBL] [Abstract][Full Text] [Related]
11. TP53 tumor-suppressor gene and human carcinogenesis.
Basset-Séguin N; Molès JP; Mils V; Dereure O; Guilhou JJ
Exp Dermatol; 1993 Jun; 2(3):99-105. PubMed ID: 8162331
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.
Gu J; Kawai H; Wiederschain D; Yuan ZM
Cancer Res; 2001 Feb; 61(4):1741-6. PubMed ID: 11245491
[TBL] [Abstract][Full Text] [Related]
13. [p53 transgenic and knockout mice].
Oda H
Nihon Rinsho; 2000 Jun; 58(6):1250-4. PubMed ID: 10879049
[TBL] [Abstract][Full Text] [Related]
14. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
15. Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
Birch JM; Heighway J; Teare MD; Kelsey AM; Hartley AL; Tricker KJ; Crowther D; Lane DP; Santibáñez-Koref MF
Br J Cancer; 1994 Dec; 70(6):1176-81. PubMed ID: 7981072
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma.
Adesina AM; Nalbantoglu J; Cavenee WK
Cancer Res; 1994 Nov; 54(21):5649-51. PubMed ID: 7923211
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the p53 gene occur in diverse human tumour types.
Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
[TBL] [Abstract][Full Text] [Related]
18. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
Evans SC; Lozano G
Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
[TBL] [Abstract][Full Text] [Related]
19. DNA damage, oncogenesis and the p53 tumour-suppressor gene.
Lee JM; Abrahamson JL; Bernstein A
Mutat Res; 1994 Jun; 307(2):573-81. PubMed ID: 7514730
[TBL] [Abstract][Full Text] [Related]
20. Role of transgenic mice in identification and characterization of tumour suppressor genes.
Sharan SK; Bradley A
Cancer Surv; 1995; 25():143-59. PubMed ID: 8718516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]